Loading...
iCAD, Inc.
ICAD•NASDAQ
Healthcare
Medical - Devices
$3.87
$0.14(3.75%)
iCAD, Inc. (ICAD) Financial Performance & Income Statement Overview
Review iCAD, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
13.22%
↑ 13.22%
Operating Income Growth
18.48%
↑ 18.48%
Net Income Growth
-15.87%
↓ 15.87%
Operating Cash Flow Growth
20.53%
↑ 20.53%
Operating Margin
-30.50%
↓ 30.50%
Gross Margin
85.57%
↑ 85.57%
Net Profit Margin
-26.77%
↓ 26.77%
ROE
-17.45%
↓ 17.45%
ROIC
-18.74%
↓ 18.74%
iCAD, Inc. (ICAD) Income Statement & Financial Overview
Review iCAD, Inc.'s (ICAD) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.41M | $4.22M | $5.03M | $4.95M |
| Cost of Revenue | $738000.00 | $583000.00 | $812000.00 | $904000.00 |
| Gross Profit | $4.67M | $3.63M | $4.22M | $4.05M |
| Gross Profit Ratio | $0.86 | $0.86 | $0.84 | $0.82 |
| R&D Expenses | $1.41M | $1.93M | $1.76M | $1.51M |
| SG&A Expenses | $4.06M | $3.67M | $4.34M | $3.98M |
| Operating Expenses | $5.54M | $5.65M | $6.10M | $5.49M |
| Total Costs & Expenses | $6.15M | $6.23M | $6.98M | $6.39M |
| Interest Income | $192000.00 | $210000.00 | $206000.00 | $203000.00 |
| Interest Expense | $12000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $174000.00 | $113000.00 | $177000.00 | $103000.00 |
| EBITDA | -$589000.00 | -$1.68M | -$1.55M | -$1.11M |
| EBITDA Ratio | -$0.11 | -$0.40 | -$0.31 | -$0.23 |
| Operating Income | -$865000.00 | -$2.02M | -$1.95M | -$1.44M |
| Operating Income Ratio | -$0.16 | -$0.48 | -$0.39 | -$0.29 |
| Other Income/Expenses (Net) | $90000.00 | $220000.00 | $217000.00 | $223000.00 |
| Income Before Tax | -$775000.00 | -$1.79M | -$1.73M | -$1.22M |
| Income Before Tax Ratio | -$0.14 | -$0.43 | -$0.34 | -$0.25 |
| Income Tax Expense | $79000.00 | $6000.00 | $8000.00 | $4000.00 |
| Net Income | -$854000.00 | -$1.80M | -$1.74M | -$1.22M |
| Net Income Ratio | -$0.16 | -$0.43 | -$0.35 | -$0.25 |
| EPS | -$0.03 | -$0.07 | -$0.07 | -$0.05 |
| Diluted EPS | -$0.03 | -$0.07 | -$0.07 | -$0.05 |
| Weighted Avg Shares Outstanding | $26.35M | $26.35M | $26.35M | $26.35M |
| Weighted Avg Shares Outstanding (Diluted) | $26.35M | $26.35M | $26.35M | $26.35M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan